Home/ Supplements/ Nattokinase/ Nattokinase NSK-SD

Nattokinase NSK-SD

product on market Capsule Klaire Labs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Nattokinase NSK-SD
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mg
Market median: 100.0mg (70 products)

Other Ingredients

Vegetarian Capsule L-Leucine Cellulose Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: 1 capsule, 2 times daily, 12 hours apart, with or between meals. Use is contraindicated in persons with history of bleeding tendency.

Warnings & Precautions

Contains: Soy.

Caution: If you are pregnant, nursing, have a medical condition, or taking prescription drugs, consult your physician before using this product.

Keep out of reach of children.

Do not use if shrinkwrap is broken or missing.

Formulation Notes

Free of the following common allergens: Milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, and yeast. Contains no artificial colors, flavors, or preservatives.

Fibrinolytic units or fibrin degradation units (FU) is a measure of enzyme activity. Nattokinase NSK-SD is standardized to contain 2,000 FU per capsule.

Produced under a strict quality management system in compliance with Good Manufacturing Practices (GMPs) and third-party quality certifications.

Additional Information

Store in a cool, dry place (59 degrees F - 85 degrees F) away from direct light.

Metadata

Product Details

UPC / SKU8 28054 00106 0
DSLD Entry Date2022-05-19
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID264948
Data Updated2026-04-11
Research

Research Evidence

4
Research Sources
45
Avg Quality
2
Rct
1
Other
1
Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023 PubMed DOI
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008 PubMed DOI
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015 PubMed DOI
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017 PubMed DOI
View all evidence for Nattokinase →
Compare

Similar Products

View all Nattokinase products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.